Celera Hopes to Translate Genetic Heart Disease Research Into Diagnostic Tool

Jan 22, 2008

NEW YORK (GenomeWeb News) – Three soon-to-be published studies suggest that a polymorphism in KIF6, a gene encoding a kinesin-like protein in the molecular motor family, increases the risk of coronary heart disease, Celera announced yesterday.

Celera subsidiary Berkeley HeartLab is developing a laboratory test, which it expects to launch in the coming months, for the gene variant.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

NIH's Collins on Harassment

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

With Eight Arms and Giant Eyes

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Missing From Trials

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

This Week in Cell

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.

Main menu